Incyte to establish European headquarters in Geneva
14 April 2015 | By Victoria White
Incyte's base for European clinical development operations is to be based in Geneva, Switzerland. Incyte is to occupy a 9,000 sq. ft. facility by mid-2015...
List view / Grid view
News
Merck Capacity Advancement Program to improve diabetes and hypertension healthcare capacity in Africa and Asia
14 April 2015 | By Victoria White
Merck is introducing diabetes management training for more than 5,000 Maharashtra University students as part of the Merck Capacity Advancement Program...
Novo Nordisk’s Changing Diabetes in Children programme extended by three years
14 April 2015 | By Victoria White
The Changing Diabetes in Children programme, a scheme that has provided free insulin to 13,000 children since 2009, has been extended by three years.
Positive Phase 2b trial results announced for IgA nephropathy treatment
14 April 2015 | By Victoria
The NEFIGAN Trial of Nefecon for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis...
UMC Utrecht’s new liver cancer treatment approved for use in Europe
14 April 2015 | By Victoria White
A new liver cancer treatment developed by the UMC Utrecht that uses uses radioactive holmium microspheres has received the European CE mark...
Merck appoints Udit Batra to head combined life science business ahead of planned Sigma-Aldrich acquisition
14 April 2015 | By Victoria White
Merck has announced that Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich...
Ichor and Janssen to collaborate to develop and commercialise immunotherapies for chronic Hepatitis B
13 April 2015 | By Victoria White
Ichor Medical Systems has announced that it has entered into a product development collaboration and worldwide license agreement with Janssen...
FDA modifies partial clinical hold on TKM-Ebola Investigational New Drug application
13 April 2015 | By Victoria White
The FDA has modified the partial clinical hold on the IND for TKM-Ebola to permit repeat dosing of healthy volunteers at a dose of 0.24 mg/kg/day...
ReNeuron files application to commence Phase I/II clinical trial with its stem cell therapy candidate for retinitis pigmentosa
13 April 2015 | By Victoria White
ReNeuron has announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to commence a Phase I/II clinical trial with its human Retinal Progenitor Cell (hRPC) therapy candidate for retinitis pigmentosa (RP).
Mechanism of action of First-in-class anti-HIV drug, ABX464, published
13 April 2015 | By Victoria White
ABIVAX, a biotechnology company developing first-in-class anti-viral drugs and vaccines, has announced publication of the mechanism of action of ABX464...
Novo Nordisk opens new insulin formulation and filling facility in Kaluga, Russia
13 April 2015 | By Victoria White
Novo Nordisk has opened a manufacturing facility in the Kaluga region of Russia for formulation and filling of modern insulin for the treatment of diabetes...
FDA grants Priority Review designation to Lifitegrast for the treatment of dry eye disease
13 April 2015 | By Victoria White
Shire has announced that the FDA has accepted for filing the New Drug Application (NDA) for Lifitegrast and granted a Priority Review designation...
FDA grants Breakthrough Therapy Designation for Viaskin Peanut for the treatment of peanut allergy in children
13 April 2015 | By Victoria White
DBV Technologies has announced that the FDA has granted Breakthrough Therapy Designation to Viaskin Peanut for children with peanut allergies...
Case study: Optimising international flows delivers step-change for global pharmaceutical manufacturer
10 April 2015 | By Yusen Logistics
Yusen Logistics was initially appointed by this leading global pharmaceutical manufacturer to implement lean principles in 2007, which involved re-engineering its European flows as part of its international requirement to deliver over 1 billion packs to patients...
Yusen Logistics’ award-winning Pharma Superhighway set to pass 1.25 million pallet milestone in 2015
Yusen Logistics’ European Pharmaceutical Superhighway is contracted to carry over 1.25 million pallets this year, providing both shared and single use solutions to highly complex supply chain requirements for customers ranging from global manufacturers to small biotech companies.
